Overview
Dr. Mark E. Wylam is a board-certified UCI Health pulmonologist and critical care physician who specializes in pulmonology and critical care medicine.He earned his medical degree from Georgetown University in Washington, D.C. He completed a combined residency in internal medicine and pediatrics at the University of Illinois in Chicago, followed by fellowships in adult pulmonary and critical care medicine at the University of Chicago. He was a consultant at the University of Chicago and later the Mayo Clinic in Rochester, Minn., for 27 years.Wylam served as an assistant professor at the University of Chicago until 1998, where he directed the bronchoscopy program. Following advanced training at Washington University and the University of Pittsburgh, he established the lung transplant program at the University of Chicago. In 1998, he joined the Mayo Clinic’s Pulmonary and Critical Care Medicine Division in Rochester, MN, to pursue additional research opportunities.As director of Mayo Clinic’s critical care program, he led the establishment of the 24/7 intensivist model, setting the industry standard. Under his leadership, practice bundles, best practice guidelines, daily checklists, a standardized case presentation format and a rapid resuscitation team were implemented. A key clinician and innovator in the Heart-Lung Transplant Program, he has also held leadership roles as past chair of pediatric critical care and adult critical care. He was the founding director of the Mayo Clinic Cystic Fibrosis Center.His research focuses on disease mechanisms, particularly vascular and airway smooth muscle function in pediatric and adult lung diseases. He pioneered the use of aerosolized GM-CSF for autoimmune alveolar proteinosis, later expanding its application to non-tuberculous mycobacterium. He also identified mollicutes, including Mycoplasma hominis, as the cause of transplant-related idiopathic hyperammonemia. His current research explores donor-specific cell-free DNA as a biomarker for transplant graft integrity. Clinically, he specializes in heart and lung transplantation, critical care, cystic fibrosis and both common and rare pulmonary conditions in pediatric and adult patients.
Dr. Wylam is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Mediastinitis, Pulmonary Alveolar Proteinosis, Acute Interstitial Pneumonia, and Lung Transplant.
Dr. Wylam is board certified in American Board Of Internal Medicine - Pulmonary Disease and American Board Of Pediatrics - Pediatric Pulmonology. He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 1 clinical trial. Dr. Wylam is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- INDEMNITY
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 The City Drive South, Building 30, Orange, CA 92868
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Keck Hospital Of USC
Toby Maher is a Pulmonary Medicine provider practicing medicine in Los Angeles, California. Dr. Maher is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Lung Transplant, and Tissue Biopsy.
Ronald Reagan UCLA Medical Center
Rajan Saggar is a Pulmonary Medicine provider practicing medicine in Los Angeles, California. Dr. Saggar is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Lung Transplant, and Thrombectomy.
UC Irvine Medical Center
Dr. Adithya Cattamanchi is a board-certified UCI Health pulmonologist who specializes in lung disorders and critical care medicine. His clinical focus is on the treatment and management of pulmonary infections as well as common lung diseases, such as asthma and chronic obstructive pulmonary disease (COPD).Cattamanchi earned his medical degree at the UC San Francisco School of Medicine, where he completed a residency in internal medicine and a fellowship in pulmonary and critical care medicine. He also received a master's of science degree in clinical research at UC San Francisco. Before joining UCI Health and the UC Irvine School of Medicine as chief of the Division of Pulmonary Diseases & Critical Care Medicine, he served as a pulmonologist and critical care medicine specialist at Zuckerberg San Francisco General Hospital and Trauma Center and as a professor with the UC San Francisco School of Medicine and its Center for Tuberculosis.His research focus is on improving the diagnosis and treatment of people with tuberculosis (TB) to ensure that the disease is diagnosed early and treatment begun immediately for better outcomes and to prevent community transmission, particularly in regions around the world with high rates of TB. Working with basic scientists and engineers to identify novel biomarkers for TB screening and diagnosis, he has developed point-of-care platforms for biomarker detection and tested them in field studies to evaluate their impact on clinical decisions and patient outcomes.Cattamanchi is the author or co-author of nearly 200 articles in peer-reviewed medical journals. His published research includes the performance of TB diagnostics among people with TB and led studies funded by the National Institutes of Health (NIH) to increase molecular testing for TB in community health centers throughout Uganda and to improve molecular diagnosis of drug-resistant TB in the Philippines. He also is working on NIH-funded studies to reduce TB in high-density U.S. urban settings and to develop novel, noninvasive tests to diagnose TB in children. Dr. Cattamanchi is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pulmonary Tuberculosis, Pneumonia, Pneumocystis Jiroveci Pneumonia, and COVID-19. Dr. Cattamanchi is board certified in American Board Of Internal Medicine - Pulmonary Disease.
Frequently Asked Questions about Dr. Mark E. Wylam
How do I make an appointment with Dr. Mark E. Wylam?
You can book an appointment with Dr. Mark E. Wylam by calling their office at 714-456-7720. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark E. Wylam a top-rated expert for Cystic Fibrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark E. Wylam is classified as an Advanced expert for Cystic Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark E. Wylam specialize in?
While Dr. Mark E. Wylam is a Intensive Care Medicine, they have specific expertise in Cystic Fibrosis, Mediastinitis, and Lung Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.
Does Dr. Mark E. Wylam participate in research or clinical trials?
Yes. Dr. Mark E. Wylam has published 39 articles and abstracts on conditions like Cystic Fibrosis. You can view a list of Dr. Mark E. Wylam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark E. Wylam accept my insurance?
Dr. Mark E. Wylam accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 714-456-7720 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cystic FibrosisDr. Wylam isAdvanced. Learn about Cystic Fibrosis.
- Lung TransplantDr. Wylam isAdvanced. Learn about Lung Transplant.
- MediastinitisDr. Wylam isAdvanced. Learn about Mediastinitis.
- Experienced
- Acute Interstitial PneumoniaDr. Wylam isExperienced. Learn about Acute Interstitial Pneumonia.
- AsthmaDr. Wylam isExperienced. Learn about Asthma.
- Bronchiolitis ObliteransDr. Wylam isExperienced. Learn about Bronchiolitis Obliterans.
- Chronic CoughDr. Wylam isExperienced. Learn about Chronic Cough.
- Chronic Eosinophilic PneumoniaDr. Wylam isExperienced. Learn about Chronic Eosinophilic Pneumonia.
- Eosinophilic PneumoniaDr. Wylam isExperienced. Learn about Eosinophilic Pneumonia.
- Hypereosinophilic SyndromeDr. Wylam isExperienced. Learn about Hypereosinophilic Syndrome.
- Hypersensitivity PneumonitisDr. Wylam isExperienced. Learn about Hypersensitivity Pneumonitis.
- Interstitial Lung DiseaseDr. Wylam isExperienced. Learn about Interstitial Lung Disease.
- Lung MetastasesDr. Wylam isExperienced. Learn about Lung Metastases.
- Newborn JaundiceDr. Wylam isExperienced. Learn about Newborn Jaundice.
- PneumoniaDr. Wylam isExperienced. Learn about Pneumonia.
- Pulmonary Alveolar ProteinosisDr. Wylam isExperienced. Learn about Pulmonary Alveolar Proteinosis.
- Pulmonary EmbolismDr. Wylam isExperienced. Learn about Pulmonary Embolism.
- Pulmonary FibrosisDr. Wylam isExperienced. Learn about Pulmonary Fibrosis.
- Secondary Immunodeficiency (SID)Dr. Wylam isExperienced. Learn about Secondary Immunodeficiency (SID).
- Simple Pulmonary EosinophiliaDr. Wylam isExperienced. Learn about Simple Pulmonary Eosinophilia.